Effects of prolonged administration of porcine calcitonin in postmenopausal osteoporosis.
D000469:Alkaline Phosphatase / Q000097:blood; D000818:Animals; D001862:Bone Resorption / Q000187:drug effects; D001842:Bone and Bones / Q000473:pathology; D002116:Calcitonin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D002118:Calcium / Q000097:blood / Q000378:metabolism / Q000652:urine; D002127:Calcium Isotopes; D002979:Climacteric; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D007279:Injections, Subcutaneous; D008274:Magnesium / Q000097:blood; D008875:Middle Aged; D010024:Osteoporosis / Q000188:drug therapy*; D010280:Parathyroid Glands / Q000502:physiology; D010281:Parathyroid Hormone / Q000097:blood; D010758:Phosphorus / Q000097:blood / Q000652:urine; D013057:Spectrum Analysis; D013552:Swine
D002127:Calcium Isotopes; D010281:Parathyroid Hormone; D010758:Phosphorus; D002116:Calcitonin; D000469:Alkaline Phosphatase; D008274:Magnesium; D006909:Hydroxyproline; D002118:Calcium